A Retrospective Molecular Epidemiology Study in Singapore Patients With Advanced Non Small Cell Lung Cancer (NSCLC) of Adenocarcinoma Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation Status

• Conditions: NSCLC
• Interventions: Other: EGFR mutation status in patients

• Registration Number: NCT01100827
• Lead Sponsor: National University Hospital, Singapore

Brief Summary

To determine EGFR mutation status in patients with advanced stage adenocarcinoma NSCLC.

To determine the association between EGFR mutation status and demographic data in advanced stage adenocarcinoma NSCLC patients.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2010-04-07
• Study First Submitted QC: 2010-04-08
• Study First Posted: 2010-04-09
• Study Start: 2013-02
• Status Verified: 2013-12
• Last Update Submitted: 2013-12-10
• Last Update Posted: 2013-12-11
• Primary Completion: 2015-02
• Study Completion: 2015-02

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Nil

Exclusion Criteria

Nil

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
EGFR mutation status in patients	EGFR mutation status in patients	-

Trial Locations

Locations (1)

National University Hospital Singapore; 🇸🇬 Singapore, Singapore